Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8307985

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8238031

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8229694

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8222586

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Embroidered Uniforms And Clothing Dys

Deadline: 31 Jul 2027

United States

Ref. No.: 8216736

EMD:Ref Document

Bid Value: Ref Document

482 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8162291

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Medicines Containing The Active Ingredient Dapagliflozin Atc A10Bk01

Deadline: 31 Jul 2026

Germany

Ref. No.: 8054393

EMD:Ref Document

Bid Value: Ref Document

117 Days Left

Broad Agency Announcement Baa For Chemical Biological Radiological Nuclear And Explosive Cbrne Defense Efforts Under Procurement Contracts Cooperative Agreements And Prototypes Under Other Transactions Agreements

Deadline: 20 Aug 2029

United States

Ref. No.: 8020715

EMD:Ref Document

Bid Value: Ref Document

1233 Days Left

Medicines Containing The Active Ingredient Interferon Beta 1A Atc L03Ab07 For Subcutaneous Use

Deadline: 31 Jul 2026

Germany

Ref. No.: 8019386

EMD:Ref Document

Bid Value: Ref Document

117 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8011777

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Open House Biologics Discount Agreements 2024 09 Golimumab

Deadline: 30 Sep 2026

Germany

Ref. No.: 7986939

EMD:Ref Document

Bid Value: Ref Document

178 Days Left

Fy25 29 Strategic Trends Research Initiative Broad Agency Announcement

Deadline: 01 Aug 2029

United States

Ref. No.: 7944451

EMD:Ref Document

Bid Value: Ref Document

1214 Days Left

Medicines Containing The Active Substance Natalizumab Atc L04Ag03

Deadline: 31 Jul 2026

Germany

Ref. No.: 7933962

EMD:Ref Document

Bid Value: Ref Document

117 Days Left

Fy25 29 Strategic Trends Research Initiative Broad Agency Announcement

Deadline: 01 Aug 2029

United States

Ref. No.: 7840092

EMD:Ref Document

Bid Value: Ref Document

1214 Days Left

Medicines Containing The Active Substance Sorafenib Atc L01Ex02

Deadline: 31 Jul 2026

Germany

Ref. No.: 7827950

EMD:Ref Document

Bid Value: Ref Document

117 Days Left

Discover Tenders by Combat Uniforms Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Combat Uniforms Sector

Filter Your Search

FREE Trial plan for all new users!